605116.SH
奥锐特
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 19.48
−2.36%Year over year
Reported trailing growth
- Revenue
- +9.2%
- EBITDA
- —
- EBIT
- +1.0%
- EPS
- +0.3%
- Free cash flow
- +155.3%
- Operating cash flow
- +80.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +19.0%
- EBITDA
- +27.8%
- EBIT
- +29.2%
- Net income
- +28.7%
- EPS
- +29.1%
- Free cash flow
- -5.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026